Supplementation of Medium-Chain Triglycerides Combined with Docosahexaenoic Acid Inhibits Amyloid Beta Protein Deposition by Improving Brain Glucose Metabolism in APP/PS1 Mice

The deterioration of brain glucose metabolism predates the clinical onset of Alzheimer’s disease (AD). Medium-chain triglycerides (MCTs) and docosahexaenoic acid (DHA) positively improve brain glucose metabolism and decrease the expression of AD-related proteins. However, the effects of the combined...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nutrients 2023-10, Vol.15 (19), p.4244
Hauptverfasser:	Wang, Zehao, Zhang, Dalong, Cheng, Cheng, Lin, Zhenzhen, Zhou, Dezheng, Sun, Yue, Li, Wen, Yan, Jing, Luo, Suhui, Qian, Zhiyong, Li, Zhenshu, Huang, Guowei
Format:	Artikel
Sprache:	eng
Schlagworte:	Advertising executives Alzheimer's disease Amyloid beta-protein Apoptosis Brain Chromatography Cognitive ability Dextrose Diet Disease prevention Energy Enzymes Fatty acids Glucose Glucose metabolism Metabolism Neurons Older people Omega-3 fatty acids Proteins Triglycerides Unsaturated fatty acids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!